Find information on Industry Analysis Report

Posts tagged ‘Sorin’

Zimmer Medical Device Company Intelligence Report

Headquartered in Warsaw, Indiana, US, Zimmer develops, manufactures and markets orthopaedic reconstructive implants (including knee, hip and extremities), spinal and trauma devices, biologics, dental implants, and related surgical products, which include surgical supplies and instruments designed to aid in surgical procedures and post-operation rehabilitation.

Zimmer is a leading supplier in the orthopaedics industry, a position which was confirmed through its October 2003 acquisition of Centerpulse AG. Centerpulse provided Zimmer with the leading position in the European reconstructive market and entry into the spine market, one of the fastest-growth segments in orthopaedics. The company’s spinal business has been expanded further with the acquisitions of Endius in April 2007 and Abbot Spine in October 2008.

Another key acquisition – in April 2004 – that has led to strong growth for Zimmer, was that of its alliance partner, Implex, the developer of Hedrocel biomaterial, which Zimmer has marketed as Trabecular Metal Technology since 2000.

More recent acquisitions have expanded Zimmer’s surgical products portfolio. These include Sodem Diffusion SA, the manufacturer of SoPlus Orthopaedic Surgical Power Tools; and Synvasive Technology, producer of Stablecut surgical saw blades and the eLibra Dynamic Knee Balancing System for soft tissue balancing.

Zimmer manages its operations through three geographic segments – the Americas (consisting principally of the US and includes other North, Central and South American markets), Europe (consisting principally of Europe and includes the Middle East and Africa) and Asia Pacific (consisting principally of Japan and Australia and includes other Asian and Pacific markets).

Zimmer has operations in more than 25 countries and sells products in over 100. In 2011, the company generated a net profit of US$760.0 million on sales of US$4,451.8 million. It employs approximately 8,700 people worldwide.

This company report provides
Overview
Key contact information
Introduction to the company and its current activities
Summary of its financial performance
Who are the company’s major competitors?
Key recent events in an “at a glance” format

Financial Review
Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available)
Table providing in-depth five-year financial analysis
Employee data, including breakdown by company division and geographic location

Strategic Focus
Investigates the company’s aims and its areas of focus

Products
Core product areas, key brands, product approvals and launches

Research and Development
How much has been invested in R&D?
Where is the research based?
What alliances and agreements does the company have and with whom?

Manufacturing and Distribution
Identifying the company’s manufacturing locations
Sales and marketing facilities

Agreements
With whom has the company reached agreements and what do they involve?
Key contracts awarded

Mergers, Acquisitions, Minority Investments, Joint Ventures and Divestments

Litigation

Key Corporate Events

For more information kindly visit :
Zimmer Medical Device Company Intelligence Report

Or

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Fax: + 91 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: http://twitter.com/#!/Sandhya3B
Our Blogs: http://bharatbook.posterous.com/
http://healthcareraj.blogspot.com/

Advertisements

Sorin Medical Device Company Intelligence Report

Sorin develops and manufactures medical technologies and therapies for cardiac surgery and for the treatment of cardiac rhythm disorders. At the end of 2008, the company completed a programme of strategic divestitures and concluded a plan to restructure its business portfolio. The divestitures included the sale of its endovascular, coronary stent and renal care businesses. This has allowed the company to better focus on its three core businesses – Cardiac Rhythm Management (CRM), Cardiopulmonary and Heart Valves.

* The CRM business produces pacemakers, implantable cardioverter defibrillators (ICDs), cardiac resynchronisation therapy defibrillators (CRT-Ds), programmers, electrodes, electrophysiology leads and holter monitors.
* The Cardiopulmonary business produces extracorporeal blood circulation systems including oxygenators, heart-lung machines, perfusion tubing sets, autotransfusion systems and disposables, cannulae and endoscopic vessel harvesting (EVH) systems.
* The Heart Valves business offers mechanical heart valves, tissue heart valves, sutureless self-anchoring tissue valves and annuloplasty rings. Sorin is also a distributor of endovascular devices.

Sorin’s recent investments in developing its business include the purchase of equity stakes in Enopace Biomedical (a company developing a neuromodulation system to treat patients with congestive heart failure) and MD Start (a venture capital incubator), as well as the acquisition of a line of arterial and venous cannulae from Endoscopic Technologies Inc and the purchase of Gish Biomedical (a producer of disposable medical devices for cardiovascular surgery).

Sorin’s principal manufacturing and R&D facilities are located in Italy, France, Germany, Canada and the US. The company is present in more than 80 countries throughout the world and serves over 5,000 public and private health institutions.

The Sorin Group was created through the demerger of Snia’s biomedical operations. It was listed separately on the Online Stock Market of the Milan Securities Exchange in January 2004. As of January 2012, its main shareholders included: Bios SpA (19.1%); Tower 6Bis Sarl (6.7%); Banca Monte Dei Paschi di Siena SpA (7.3%); Unipol Assicurazioni SpA (4.6%); GE Capital Equity Holdings (6.4%); and Norges Bank (2.0%).

In 2011, Sorin generated net income of EUR58 million on sales of EUR743 million. The company employs more than 3,740 people worldwide.

This company report provides
Overview
Key contact information
Introduction to the company and its current activities
Summary of its financial performance
Who are the company’s major competitors?
Key recent events in an “at a glance” format

Financial Review
Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available)
Table providing in-depth five-year financial analysis
Employee data, including breakdown by company division and geographic location

Strategic Focus
Investigates the company’s aims and its areas of focus

Products
Core product areas, key brands, product approvals and launches

Research and Development
How much has been invested in R&D?
Where is the research based?
What alliances and agreements does the company have and with whom?

Manufacturing and Distribution
Identifying the company’s manufacturing locations
Sales and marketing facilities

Agreements
With whom has the company reached agreements and what do they involve?
Key contracts awarded

Mergers, Acquisitions, Minority Investments, Joint Ventures and Divestments

Litigation

Key Corporate Events

For more information kindly visit :
Sorin Medical Device Company Intelligence Report

Or

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Fax: + 91 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: http://twitter.com/#!/Sandhya3B
Our Blogs: http://bharatbook.posterous.com/
http://healthcareraj.blogspot.com/

Tag Cloud